J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Medical Genetics 2006;43:e23; doi:10.1136/jmg.2005.037598
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, D O
Right arrow Articles by Sillibourne, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, D O
Right arrow Articles by Sillibourne, J
Right arrowPubmed/NCBI databases
*OMIM
Topic Collections
Right arrow JMG Online mutation reports

ONLINE MUTATION REPORT

Oculopharyngeal muscular dystrophy: a point mutation which mimics the effect of the PABPN1 gene triplet repeat expansion mutation

D O Robinson1, A J Wills3, S R Hammans4, S P Read2, J Sillibourne2

1 Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK and Human Genetics Division, Southampton University School of Medicine, Southampton, UK
2 Wessex Regional Genetics Laboratory, Salisbury District Hospital
3 Institute of Neuroscience, Queen’s Medical Centre, Nottingham, UK
4 Wessex Neurology Centre, Southampton University School of Medicine

Correspondence to:
Dr David O Robinson
Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, Wiltshire SP2 8BJ, UK; david.robinson{at}salisbury.nhs.uk] Background: Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant late onset neuromuscular disease characterised by proximal muscle weakness, ptosis, and swallowing difficulty. The only causative mutation described to date is a triplet repeat expansion consisting of two to seven additional base triplets in a repeat sequence in exon 1 of the polyadenine binding protein nuclear 1 (PABPN1) gene. This results in an increase in length of a polyalanine tract in the PABPN1 protein from 10 to 12–17 residues.

Objective: Description of another mutation in a case of OPMD.

Methods: Sequence analysis of exon 1 of the PABPN1 gene was undertaken on 202 patients referred for a possible diagnosis of OPMD but negative for the triplet repeat expansion mutation.

Results: A case was identified with typical symptoms of OPMD, negative for the repeat expansion mutation but with a missense mutation in PABPN1 close to the 3' end of the normal polyalanine codon repeat sequence.

Conclusions: The single base mutation changes a glycine codon to an alanine codon and results in an increase in the number of contiguous polyalanine codons. This mimics the effect of the common triplet repeat expansion mutation and represents a previously undescribed mechanism of mutation.


Abbreviations: OPMD, oculopharyngeal muscular dystrophy

Keywords: PABPN1; oculopharyngeal muscular dystrophy; triplet repeat expansion; polyalanine




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
D Rivera, H Mejia-Lopez, E N Pompa-Mera, C Villanueva-Mendoza, A Nava-Castaneda, L Garnica-Hayashi, S Cuevas-Covarrubias, and J C Zenteno
Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects
Br. J. Ophthalmol., July 1, 2008; 92(7): 998 - 1002.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.